Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT05504395
A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 14, 2022
Completion: Feb 21, 2023
Loading map...